(Q69299648)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2523762%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

title

GR38032F, a 5HT3 receptor antagonist, in the prophylaxis of acute cisplatin-induced nausea and vomiting (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2523762%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

author name string

M Marty

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2523762%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

J P Droz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2523762%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

P Pouillart

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2523762%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

B Paule

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2523762%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

N Brion

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2523762%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

J Bons

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2523762%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

publication date

1 January 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2523762%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

30 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2523762%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2523762%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2523762%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

page(s)

389-391

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2523762%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00435842

30 September 2019

exact match

0 references

cites work

Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.

1 reference

12 December 2020

Dose-response relationships of the objective and subjective antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesis.

1 reference

12 December 2020

Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy

1 reference

12 December 2020

Peripheral 5-hydroxytryptamine receptors and their classification

1 reference

12 December 2020

Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin

1 reference

12 December 2020

Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research.

1 reference

12 December 2020

Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism

1 reference

12 December 2020

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting

1 reference

12 December 2020

High-dose metoclopramide in cancer chemotherapy-induced nausea and vomiting

1 reference

12 December 2020

Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00435842

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2523762%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

30 September 2019

0 references

1 reference